Inessa Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 2.21 Cr
as on 04-12-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Inessa Nutraceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 2.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Choudhary, Sangeeta Jain, and Tanuja serve as directors at the Company.
- CIN/LLPIN
U24290DL2021PTC389883
- Company No.
389883
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Inessa Nutraceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Choudhary  | Director | 15-Nov-2021 | Current |
| Sangeeta Jain | Director Appointed In Casual Vacancy | 27-Sep-2022 | Current |
| Tanuja | Director | 13-Aug-2022 | Current |
Financial Performance of Inessa Nutraceuticals.
Enhance accessibility to Inessa Nutraceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Inessa Nutraceuticals?
Unlock access to Inessa Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vokin Biotech Private LimitedActive 18 years 2 monthsAmit Choudhary, Sangeeta Jain and 1 more are mutual person
Perennial Lifesciences Private LimitedActive 15 years 7 monthsAmit Choudhary, Sangeeta Jain and 1 more are mutual person
- Kansal Enterprises Private LimitedActive 14 years 8 months
Amit Choudhary, Sangeeta Jain and 1 more are mutual person
- Bumyoung Wellness Private LimitedActive 3 years 1 month
Amit Choudhary, Sangeeta Jain and 1 more are mutual person
- Kanishka Vinyl Private LimitedActive 13 years 4 months
Amit Choudhary, Sangeeta Jain and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inessa Nutraceuticals?
Inessa Nutraceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inessa Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inessa Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
